癌の画像診断、重要所見を見逃さない

出版社: 羊土社
著者:
発行日: 2018-10-20
分野: 臨床医学:一般  >  画像/超音波
ISBN: 9784758111898
電子書籍版: 2018-10-20 (第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:8~14営業日

4,400 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,400 円(税込)

商品紹介

全身を1冊で網羅した今までにない癌の画像診断入門書.診る機会の多い癌に絞って早期発見のコツ・腫瘤発見時の対応・ステージング・良/悪性の鑑別を平易に解説.解剖やリンパ節の解説もあり,全ての医師にお勧め!

目次

  • 第1章 頭頸部の画像診断 脳腫瘍,甲状腺腫瘤に強くなろう
     1.脳腫瘍診断の基本を学ぼう ~梗塞と間違えるな!~
     2.神経膠腫の悪性度を画像から判定するには?
     3.甲状腺腫瘤を偶然に発見したときの適切な対応とは?

    第2章 肺癌の画像診断 スクリーニングからステージング・鑑別診断まで
     1.すりガラス状結節に遭遇したら?
     2.肺癌のステージングのポイントは? ~肺癌取扱い規約改訂をうけて~
     3.肺癌との鑑別が必要な良性結節 ~この所見があれば良性!~

    第3章 消化管癌の画像診断 CT・MRIでもここまでわかります!
     1.腹腔内播種の診断ポイント ~腹膜や大網を意識した読影を~
     2.消化器癌のCT・MRIによる診断ポイント ~食道,胃,大腸~
     3.胃粘膜下腫瘍の画像診断 ~GISTを中心に~

    第4章 肝・胆道の画像診断 肝細胞癌から良性の肝腫瘤まで
     1.肝細胞癌を正確に診断しよう! ~EOB–MRIを踏まえて~
     2.治療に直結する肝細胞癌の読影ポイントは? ~門脈腫瘍栓に注意!~
     3.肝細胞癌との鑑別が必要な肝腫瘍 ~これだけは知っておこう!~

    第5章 膵癌の画像診断 スクリーニングからステージング・鑑別診断まで
     1.膵癌を見逃すな! ~単純CTでもここまで診断できる!~
     2.膵癌のステージングのポイント ~この症例って手術適応?
     3.膵癌と間違えやすい非腫瘍性病変 ~鑑別のポイント~

    第6章 泌尿器科領域(腎臓・副腎・前立腺)の悪性腫瘍 副腎結節をみたら?
     1.偶発的に遭遇する副腎結節のマネジメント
     2.前立腺癌の診断ポイント ~ステージングとPI-RADSを中心に~
     3.腎腫瘤診断のポイント ~嚢胞性腫瘤の鑑別,腎細胞癌の病期分類~

    第7章 婦人科領域(子宮・卵巣)の悪性腫瘍 鑑別診断のコツ
     1.偶発的に発見された付属器腫瘤のマネジメント
     2.子宮頸癌と子宮体癌 ~ステージングのポイント~
     3.卵巣腫瘤の診断ポイント ~良性/悪性の鑑別を中心に~

    第8章 悪性リンパ腫の画像診断 典型的なサインやPETの有用性に関して
     1.腹部の多発リンパ節腫脹 ~悪性リンパ腫を疑う所見とは?~
     2.悪性リンパ腫のステージングと治療効果判定 ~FDG–PET/CTを中心に~
     3.多発リンパ節腫大の鑑別 ~転移と悪性リンパ腫以外に考慮すべきは?~

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 頭頸部の画像診断 脳腫瘍, 甲状腺腫瘤に強くなろう

P.22 掲載の参考文献
1) George AE, et al:White matter buckling:CT sign of extraaxial intracranial mass. AJR Am J Roentgenol, 135:1031-1036, 1980
2) Goldsher D, et al:Dural "tail" associated with meningiomas on Gd-DTPA-enhanced MR images:characteristics, differential diagnostic value, and possible implications for treatment. Radiology, 176:447-450, 1990
3) Drevelegas A:Extra-axial brain tumors. Eur Radiol, 15:453-467, 2005
4) [Diagnostic Imaging:Brain, 3rd Edition] (Osborn AG, et al), Elsevier, 2016
5) Higano S, et al:Malignant astrocytic tumors:clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology, 241:839-846, 2006
6) Sugahara T, et al:Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol, 171:1479-1486, 1998
7) Law M, et al:Gliomas:predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology, 247:490-498, 2008
8) Padma MV, et al:Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol, 64:227-237, 2003
9) Borbely K, et al:Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. J Neurol Sci, 246:85-94, 2006
10) Singhal T, et al:11C-methionine PET for grading and prognostication in gliomas:a comparison study with 18F-FDG PET and contrast enhancement on MRI. J Nucl Med, 53:1709-1715, 2012
11) [WHO Classification of Tumours of the Central Nervous System. WHO Classification of Tumours, Revised 4th Edition, Volume 1] (Louis DN, eds), International Agency for Research on Cancer, 2016
12) Smits M & van den Bent MJ:Imaging Correlates of Adult Glioma Genotypes. Radiology, 284:316-331, 2017
13) Louis DN, et al:The 2016 World Health Organization Classification of Tumors of the Central Nervous System:a summary. Acta Neuropathol, 131:803-820, 2016
14) Smith-Bindman R, et al:Risk of thyroid cancer based on thyroid ultrasound imaging characteristics:results of a population-based study. JAMA Intern Med, 173:1788-1796, 2013
15) Tessler FN, et al:ACR Thyroid Imaging, Reporting and Data System (TI-RADS):White Paper of the ACR TI-RADS Committee. J Am Coll Radiol, 14:587-595, 2017
16) Hoang JK, et al:Managing incidental thyroid nodules detected on imaging:white paper of the ACR Incidental Thyroid Findings Committee. J Am Coll Radiol, 12:143-150, 2015
17) Bahl M, et al:Trends in incidentally identified thyroid cancers over a decade:a retrospective analysis of 2,090 surgical patients. World J Surg, 38:1312-1317, 2014
18) Ho TY, et al:Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine, 40:297-302, 2011
19) Choi JY, et al:Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT:clinical significance and improved characterization. J Nucl Med, 47:609-615, 2006
20)「甲状腺腫瘍診療ガイドライン 2010年版」(日本内分泌外科学会, 日本甲状腺外科学会/編), 金原出版, 2010

第2章 肺癌の画像診断 スクリーニングからステージング・鑑別診断まで

P.41 掲載の参考文献
1) Naidich DP, et al:Recommendations for the management of subsolid pulmonary nodules detected at CT:a statement from the Fleischner Society. Radiology, 266:304-317, 2013
2) 楠本昌彦:肺野結節~すりガラス状結節の診断の基本を教えてください. 特集「ビギナーのための胸部画像診断-Q&Aアプローチ」, 画像診断, 34:832-833, 2014
3)「低線量CTによる肺がん検診の肺結節の判定基準と経過観察の考え方 第4版」(日本CT検診学会肺がん診断基準部会/編), 2016. http://www.jscts.org/pdf/guideline/gls4th201611.pdf
4) MacMahon H, et al:Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images:From the Fleischner Society 2017. Radiology, 284:228-243, 2017
5) Winer-Muram HT:The solitary pulmonary nodule. Radiology, 239:34-49, 2006
6) Erasmus JJ, et al:Solitary pulmonary nodules:Part I. Morphologic evaluation for differentiation of benign and malignant lesions. Radiographics, 20:43-58, 2000
7) Kuriyama K, et al:Prevalence of air bronchograms in small peripheral carcinomas of the lung on thin-section CT:comparison with benign tumors. AJR Am J Roentgenol, 156:921-924, 1991
8) Swensen SJ, et al:Lung nodule enhancement at CT:multicenter study. Radiology, 214:73-80, 2000
9)「臨床・病理 肺癌取扱い規約 第8版」(日本肺癌学会/編), 金原出版, 2017
10) Ratto GB, et al:Chest wall involvement by lung cancer:computed tomographic detection and results of operation. Ann Thorac Surg, 51:182-188, 1991
11) 横隔膜の神経支配. 「グレイ解剖学 原著第2版」(Drake RL, et al/著, 塩田浩平 他/訳), p. 114, エルゼビア・ジャパン, 2011
12) 酒井文和, 他:肺門型肺癌. 「臨時増刊号 読影レポートのエッセンス-common disease診断の要点と表現のコツ-」, 画像診断, 32:s98-s100, 2012
13) Fischer B, et al:Preoperative staging of lung cancer with combined PET-CT. N Engl J Med, 361:32-39, 2009
14) Li J, et al:Meta-analysis:accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer patients. Surg Oncol, 22:151-155, 2013
15) Wang CW, et al:Intrapulmonary lymph nodes:computed tomography findings with histopathologic correlations. Clin Imaging, 37:487-492, 2013
16) Siegelman SS, et al:Pulmonary hamartoma:CT findings. Radiology, 160:313-317, 1986
17) Nam JE, et al:Air-trapping zone surrounding sclerosing hemangioma of the lung. J Comput Assist Tomogr, 26:358-361, 2002
18) Munden RF & Libshitz HI:Rounded atelectasis and mesothelioma. AJR Am J Roentgenol, 170:1519-1522, 1998

第3章 消化管癌の画像診断 CT・MRIでもここまでわかります !

P.58 掲載の参考文献
1) Yoo E, et al:Greater and lesser omenta:normal anatomy and pathologic processes. Radiographics, 27:707-720, 2007
2) Wu LM, et al:18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer:a systematic review and meta-analysis. J Gastroenterol Hepatol, 27:472-480, 2012
3) Wakelin SJ, et al:A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol, 41:161-167, 2002
4) 5. 消化管「画像診断ガイドライン 2016年版 第2版」(日本医学放射線学会/編), pp367-369, 金原出版, 2016
5)「臨床・病理 食道癌取扱い規約 第11版」(日本食道学会/編). 金原出版, 2015
6) Picus D, et al:Computed tomography in the staging of esophageal carcinoma. Radiology, 146:433-438, 1983
7) 今井裕, 川田秀一:食道. 「癌取扱い規約からみた悪性腫瘍の病期診断と画像診断2012年版」, 臨床放射線 2012年10月臨時増刊号, 57:1431-1443, 2012
8) Ba-Ssalamah A, et al:Dedicated multi-detector CT of the esophagus:spectrum of diseases. Abdom Imaging, 34:3-18, 2009
9) van Westreenen HL, et al:Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol, 22:3805-3812, 2004
10) Kumano S, et al:T-staging of gastric cancer of air-filling multidetector-row CT:comparison with hydro-multidetector-row CT. Eur J Radiol, 81:2953-2960, 2012
11)「胃癌取扱い規約 第15版」, (日本胃癌学会/編), 金原出版, 2017
12) Kim EY, et al:The value of PET/CT for preoperative staging of advanced gastric cancer:comparison with contrast-enhanced CT. Eur J Radiol, 79:183-188, 2011
13) Mathur P, et al:Comparison of CT and MRI in the pre-operative staging of rectal adenocarcinoma and prediction of circumferential resection margin involvement by MRI. Colorectal Dis, 5:396-401, 2003
14) Furey E & Jhaveri KS:Magnetic resonance imaging in rectal cancer. Magn Reson Imaging Clin N Am, 22:165-190, v-vi, 2014
15) 長谷川貴, 他:直腸癌のMRI診断. 「特集:消化管の画像診断-腫瘍診断を中心に-」, 日独医報, 58:62-70, 2013
16) Merkel S, et al:The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis, 16:298-304, 2001
17) Gowdra Halappa V, et al:Rectal imaging:part 1, High-resolution MRI of carcinoma of the rectum at 3 T. AJR Am J Roentgenol, 199:W35-W42, 2012
18)「大腸癌取扱い規約 第9版」(大腸癌研究会/編), 金原出版, 2018
20) Hotta M, et al:Diagnostic performance of 18F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer:a comparison study with conventional PET/CT and pelvic MRI. Cancer Imaging, 18:4-11, 2018
21) Sugihara K, et al:Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum, 49:1663-1672, 2006
22) Ghanem N, et al:Computed tomography in gastrointestinal stromal tumors. Eur Radiol, 13:1669-1678, 2003
23) Miettinen M & Lasota J:Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch, 438:1-12, 2001
24) Burkill GJ, et al:Malignant gastrointestinal stromal tumor:distribution, imaging features, and pattern of metastatic spread. Radiology, 226:527-532, 2003
25) Warakaulle DR & Gleeson F:MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate. AJR Am J Roentgenol, 186:510-515, 2006
26) Antoch G, et al:Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med, 45:357-365, 2004
27) Choi YR, et al:Differentiation of large (>- 5cm) gastrointestinal stromal tumors from benign subepithelial tumors in the stomach:radiologists' performance using CT. Eur J Radiol, 83:250-260, 2014

第4章 肝・胆道の画像診断 肝細胞癌から良性の肝腫瘤まで

P.76 掲載の参考文献
1)「画像診断ガイドライン 2016年版 第2版」(日本医学放射線学会/編), 金原出版, 2016
2)「肝癌診療ガイドライン 2017年版 第4版」(日本肝臓学会/編), 金原出版, 2017
3) Narita M, et al:Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol, 44:793-798, 2009
4) Doo KW, et al:"Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR Am J Roentgenol, 193:W490-W496, 2009
5) Asayama Y, et al:Arterial blood supply of hepatocellular carcinoma and histologic grading:radiologic-pathologic correlation. AJR Am J Roentgenol, 190:W28-W34, 2008
6) Kitao A, et al:The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis:correlation with gadoxetic acid enhanced MR imaging. Eur Radiol, 21:2056-2066, 2011
7) Kadoya M, et al:Hepatocellular carcinoma:correlation of MR imaging and histopathologic findings. Radiology, 183:819-825, 1992
8) Enomoto S, et al:Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis. Hepatol Int, 5:730-737, 2011
9) Nishie A, et al:Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma. Eur J Radiol, 80:e29-e33, 2011
10)「臨床・病理 原発性肝癌取扱い規約 第6版」(日本肝癌研究会/編), 金原出版, 2015
11) Yamashita Y, et al:Cavernous hemangioma of the liver:pathologic correlation with dynamic CT findings. Radiology, 203:121-125, 1997
12) McNicholas MM, et al:T2 relaxation times of hypervascular and non-hypervascular liver lesions:do hypervascular lesions mimic haemangiomas on heavily T2-weighted MR images? Clin Radiol, 51:401-405, 1996
13) Kato H, et al:Atypically enhancing hepatic cavernous hemangiomas:high-spatial-resolution gadolinium-enhanced triphasic dynamic gradient-recalled-echo imaging findings. Eur Radiol, 11:2510-2515, 2001
14) Brancatelli G, et al:Focal nodular hyperplasia:CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology, 219:61-68, 2001
15) Grazioli L, et al:Hepatocellular adenoma and focal nodular hyperplasia:value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology, 262:520-529, 2012
16) Chung YE, et al:Varying appearances of cholangiocarcinoma:radiologic-pathologic correlation. Radiographics, 29:683-700, 2009
17) Soyer P, et al:Detection of hypovascular hepatic metastases at triple-phase helical CT:sensitivity of phases and comparison with surgical and histopathologic findings. Radiology, 231:413-420, 2004
18) Yu JS & Rofsky NM:Hepatic metastases:perilesional enhancement on dynamic MRI. AJR Am J Roentgenol, 186:1051-1058, 2006
19) 上野彰久:III .肝臓. 「腹部のCT 第3版」(陣崎雅弘/編), メディカル・サイエンス・インターナショナル, 2017より改変

第5章 膵癌の画像診断 スクリーニングからステージング・鑑別診断まで

P.95 掲載の参考文献
1) 「膵癌取扱い規約 第7版」(日本膵臓学会/編), 金原出版, 2016
2) Ahn SS, et al:Indicative findings of pancreatic cancer in prediagnostic CT. Eur Radiol, 19:2448-2455, 2009
3) Zylak C & Pallie W:Correlative anatomy and computed tomography:a module on the pancreas and posterior abdominal wall. Radiographics, 1:61-83, 1981
4) Gangi S, et al:Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer:retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol, 182:897-903, 2004
5) Bronstein YL, et al:Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol, 182:619-623, 2004
6) Wagner M, et al:Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg, 91:586-594, 2004
7) 高橋護, 竹原康雄:膵. 「特集 癌取扱い規約からみた悪性腫瘍の病期診断と画像診断2013年版」, 臨床放射線, 58:1537-1550, 2013
8) Tempero MA, Malafa MP, AI-Hawary M, et al. Pancreatic Adenocarcinoma, Version 2. 2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 15:1028-1061, 2017
9) Al-Hawary MM, et al:Pancreatic ductal adenocarcinoma radiology reporting template:consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology, 270:248-260, 2014
10) Chang ST, et al:Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care. Radiology, 281:816-825, 2016
11) Mochizuki K, et al:MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma:correlation with en bloc pathological specimens and diagnostic accuracy. Eur Radiol, 20:1757-1767, 2010
12) 厚生労働省難治性膵疾患調査研究班・日本膵臓学会:自己免疫性膵炎ガイドライン2013. 膵臓, 28:718-783, 2013
13) Sahani DV, et al:Autoimmune pancreatitis:disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology, 250:118-129, 2009
14) Ichikawa T, et al:Duct-penetrating sign at MRCP:usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology, 221:107-116, 2001
15) Wakabayashi T, et al:Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation:comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol, 98:2679-2687, 2003
16) Ishigami K, et al:Differential diagnosis of groove pancreatic carcinomas vs. groove pancreatitis:usefulness of the portal venous phase. Eur J Radiol, 74:e95-e100, 2010
17) Blasbalg R, et al:MRI features of groove pancreatitis. AJR Am J Roentgenol, 189:73-80, 2007

第6章 泌尿器科領域 ( 腎臓・副腎・前立腺 ) の悪性腫瘍 副腎結節をみたら ?

P.115 掲載の参考文献
1) Zeiger MA, et al:The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract, 15 Suppl 1:1-20, 2009
2) Boland GW, et al:Characterization of adrenal masses using unenhanced CT:an analysis of the CT literature. AJR Am J Roentgenol, 171:201-204, 1998
3) 7. 泌尿器. 「画像診断ガイドライン 2016年版 第2版」(日本医学放射線学会/編), pp490-491, 金原出版, 2016
4) Choyke PL, ACR Committee on Appropriateness Criteria.:ACR Appropriateness Criteria on incidentally discovered adrenal mass. J Am Coll Radiol, 3:498-504, 2006
5) Blake MA, et al:Adrenal imaging. AJR Am J Roentgenol, 194:1450-1460, 2010
6) Caoili EM, et al:Adrenal masses:characterization with combined unenhanced and delayed enhanced CT. Radiology, 222:629-633, 2002
7) 北島一宏, 他:前立腺癌-手術前に知りたい画像情報-「特集 泌尿器・婦人科画像診断step further-低侵襲治療時代の主治医の視点-」, 画像診断, 32:266-275, 2012
8) Weinreb JC, et al:PI-RADS Prostate Imaging - Reporting and Data System:2015, Version 2. Eur Urol, 69:16-40, 2016
9) 第1部-C 臨床病期記載法. 「泌尿器科・病理・放射線科 前立腺癌取扱い規約 第4版」(日本泌尿器科学会, 日本病理学会, 日本医学放射線学会/編), pp40-41, 金原出版, 2010
10) Yu KK, et al:Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging:multivariate feature analysis. Radiology, 202:697-702, 1997
11) Israel GM & Bosniak MA:Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). AJR Am J Roentgenol, 181:627-633, 2003
12) Kim DY, et al:Malignant renal cysts:diagnostic performance and strong predictors at MDCT. Acta Radiol, 51:590-598, 2010
13) Smith AD, et al:Bosniak category IIF and III cystic renal lesions:outcomes and associations. Radiology, 262:152-160, 2012
14) Roy C Sr, et al:Significance of the pseudocapsule on MRI of renal neoplasms and its potential application for local staging:a retrospective study. AJR Am J Roentgenol, 184:113-120, 2005
15) Jinzaki M, et al:Double-phase helical CT of small renal parenchymal neoplasms:correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr, 24:835-842, 2000
16) Ascenti G, et al:Contrast-enhanced second-harmonic sonography in the detection of pseudocapsule in renal cell carcinoma. AJR Am J Roentgenol, 182:1525-1530, 2004
17) 第1部-C 治療前臨床的総合判定. 「泌尿器科・病理・放射線科 腎癌取扱い規約 第4版」(日本泌尿器科学会, 日本病理学会, 日本医学放射線学会/編), pp40-41, 金原出版, 2011
18) 陣崎雅弘, 他:泌尿器系腫瘍 腎. 「特集 癌取扱い規約からみた悪性腫瘍のステージングと画像診断2012年版」, 臨床放射線, 57:1505-1519, 2012
19) Takahashi S, et al:Renal cell carcinoma:preoperative assessment for enucleative surgery with angiography, CT, and MRI. J Comput Assist Tomogr, 20:863-870, 1996
20) Zhang J, et al:Solid renal cortical tumors:differentiation with CT. Radiology, 244:494-504, 2007
21) Jinzaki M, et al:Renal angiomyolipoma:a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging, 39:588-604, 2014

第7章 婦人科領域 ( 子宮・卵巣 ) の悪性腫瘍 鑑別診断のコツ

P.137 掲載の参考文献
1) Modesitt SC, et al:Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstet Gynecol, 102:594-599, 2003
2) Patel MD, et al:Managing incidental findings on abdominal and pelvic CT and MRI, part 1:white paper of the ACR Incidental Findings Committee II on adnexal findings. J Am Coll Radiol, 10:675-681, 2013
3) 「画像診断ガイドライン 2016年版 第2版」(日本医学放射線学会/編), 金原出版, 2016
4) 「子宮頸癌取扱い規約 病理編 第4版」(日本産科婦人科学会, 日本病理学会/編), 金原出版, 2017
5) Balleyguier C, et al:Staging of uterine cervical cancer with MRI:guidelines of the European Society of Urogenital Radiology. Eur Radiol, 21:1102-1110, 2011
6) 「子宮頸癌治療ガイドライン 2017年版」(日本婦人科腫瘍学会), 金原出版, 2017
7) Yamashita Y, et al:Carcinoma of the cervix:dynamic MR imaging. Radiology, 182:643-648, 1992
8) Mitchell DG, et al:Early invasive cervical cancer:MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study. Gynecol Oncol, 112:95-103, 2009
9) Choi HJ, et al:Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer:meta-analysis. Cancer Sci, 101:1471-1479, 2010
10) Sakuragi N, et al:Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma. Acta Obstet Gynecol Scand, 79:311-316, 2000
11) 「子宮体がん治療ガイドライン 2013年版 第3版」(日本婦人科腫瘍学会/編), 金原出版, 2013
12) Scoutt LM, et al:Junctional zone of the uterus:correlation of MR imaging and histologic examination of hysterectomy specimens. Radiology, 179:403-407, 1991
13) Sala E, et al:Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer, 19:141-146, 2009
14) Lee YJ, et al:MR assessment of myometrial invasion in women with endometrial cancer:discrepancy between T2-weighted imaging and contrast-enhanced T1-weighted imaging. Abdom Radiol (NY), 41:127-135, 2016
15) Fujii S, et al:Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging. Eur J Radiol, 84:581-589, 2015
16) Andreano A, et al:MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer:a systematic review and meta-analysis. Eur Radiol, 24:1327-1338, 2014
17) 「子宮体癌取扱い規約 病理編 第4版」(日本産科婦人科学会, 日本病理学会/編), 金原出版, 2017
18) Manfredi R, et al:Local-regional staging of endometrial carcinoma:role of MR imaging in surgical planning. Radiology, 231:372-378, 2004
19) Atri M, et al:Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer:Results of ACRIN 6671/GOG 0233 Trial. Radiology, 283:450-459, 2017
20) Togashi K, et al:Endometrial cysts:diagnosis with MR imaging. Radiology, 180:73-78, 1991
21) Sugimura K, et al:MRI in predicting the response of ovarian endometriomas to hormone therapy. J Comput Assist Tomogr, 20:145-150, 1996
22) Kobayashi H, et al:Risk of developing ovarian cancer among women with ovarian endometrioma:a cohort study in Shizuoka, Japan. Int J Gynecol Cancer, 17:37-43, 2007
23) Tanaka YO, et al:MRI of endometriotic cysts in association with ovarian carcinoma. AJR Am J Roentgenol, 194:355-361, 2010
24) Kataoka M, et al:MR imaging of mullerian mucinous borderline tumors arising from endometriotic cysts. J Comput Assist Tomogr, 26:532-537, 2002
25) Manabe T, et al:Magnetic resonance imaging of endometrial cancer and clear cell cancer. J Comput Assist Tomogr, 31:229-235, 2007
26) Hricak H, et al:Complex adnexal masses:detection and characterization with MR imaging--multivariate analysis. Radiology, 214:39-46, 2000
27) Stevens SK, et al:Ovarian lesions:detection and characterization with gadolinium-enhanced MR imaging at 1.5 T. Radiology, 181:481-488, 1991
28) Thomassin-Naggara I, et al:Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol, 19:1544-1552, 2009
29) Thomassin-Naggara I, et al:Characterization of complex adnexal masses:value of adding perfusion-and diffusion-weighted MR imaging to conventional MR imaging. Radiology, 258:793-803, 2011
30) Siegelman ES & Outwater EK:Tissue characterization in the female pelvis by means of MR imaging. Radiology, 212:5-18, 1999
31) Kido A, et al:Dermoid cysts of the ovary with malignant transformation:MR appearance. AJR Am J Roentgenol, 172:445-449, 1999
32) Torashima M, et al:The value of detection of flow voids between the uterus and the leiomyoma with MRI. J Magn Reson Imaging, 8:427-431, 1998
33) Troiano RN, et al:Fibroma and fibrothecoma of the ovary:MR imaging findings. Radiology, 204:795-798, 1997
34) Moon WJ, et al:Brenner tumor of the ovary:CT and MR findings. J Comput Assist Tomogr, 24:72-76, 2000

第8章 悪性リンパ腫の画像診断 典型的なサインやPETの有用性に関して

P.153 掲載の参考文献
1) Rajiah P, et al:Imaging of uncommon retroperitoneal masses. Radiographics, 31:949-976, 2011
2) Hardy SM:The sandwich sign. Radiology, 226:651-652, 2003
3) Barrington SF, et al:Role of imaging in the staging and response assessment of lymphoma:consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol, 32:3048-3058, 2014
4) Elstrom R, et al:Utility of FDG-PET scanning in lymphoma by WHO classification. Blood, 101:3875-3876, 2003
5) Tsukamoto N, et al:The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma:relation to histologic subtypes based on the World Health Organization classification. Cancer, 110:652-659, 2007
6) Weiler-Sagie M, et al:(18)F-FDG avidity in lymphoma readdressed:a study of 766 patients. J Nucl Med, 51:25-30, 2010
7) Baba S, et al:Impact of FDG-PET/CT in the management of lymphoma. Ann Nucl Med, 25:701-716, 2011
8) Cheson BD, et al:Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma:the Lugano classification. J Clin Oncol, 32:3059-3068, 2014
9) Meignan M, et al:Report on the First International Workshop on Interim-PET-Scan in Lymphoma. Leuk Lymphoma, 50:1257-1260, 2009
10) Biggi A, et al:International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma:interpretation criteria and concordance rate among reviewers. J Nucl Med, 54:683-690, 2013
11) Rossi C, et al:Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients. J Nucl Med, 55:569-573, 2014
12) Gallamini A, et al:The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. Haematologica, 99:1107-1113, 2014
13) Safar V, et al:Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab. J Clin Oncol, 30:184-190, 2012
14) Borchmann P, et al:Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18):an open-label, international, randomised phase 3 study by the German Hodgkin Study Group. Lancet Oncol, 18:454-463, 2017
15) Press OW, et al:US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging:Southwest Oncology Group S0816. J Clin Oncol, 34:2020-2027, 2016
16) Swinnen LJ, et al:Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning:ECOG-ACRIN Cancer Research Group study (E3404). Br J Haematol, 170:56-65, 2015
17) Johnson P, et al:Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. N Engl J Med, 374:2419-2429, 2016
18) Lee WK, et al:CT appearances of abdominal tuberculosis. Clin Radiol, 67:596-604, 2012
19) Hulnick DH, et al:Abdominal tuberculosis:CT evaluation. Radiology, 157:199-204, 1985
20) Yoshimitsu K, et al:Unusual hemodynamics and pseudolesions of the noncirrhotic liver at CT. Radiographics, 21 Spec No:S81-S96, 2001
21) Bein ME, et al:A reevaluation of intrathoracic lymphadenopathy in sarcoidosis. AJR Am J Roentgenol, 131:409-415, 1978
22) Koyama T, et al:Radiologic manifestations of sarcoidosis in various organs. Radiographics, 24:87-104, 2004
23) Warshauer DM & Lee JK:Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol, 182:15-28, 2004
25) Mostard RL, et al:Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med, 105:1917-1924, 2011
26) Sobic-Saranovic D, et al:FDG PET imaging in sarcoidosis. Semin Nucl Med, 43:404-411, 2013
27) Ohira H, et al:18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging, 38:1773-1783, 2011

付録 リンパ節アトラス

P.182 掲載の参考文献
1) 「頭頸部癌取扱い規約 第6版」(日本頭頸部癌学会/編), 金原出版, 2018
2) [AJCC Cancer Staging Atlas:A Companion to the Seventh Editions of the AJCC Cancer Staging Manual and Handbook, 2nd ed] (Compton CC, et al, eds), pp34-40, Springer, 2012
3) Harish K:Neck dissections:radical to conservative. World J Surg Oncol, 3:21, 2005
4) 「臨床・病理 肺癌取扱い規約 第8版」(日本肺癌学会/編), 金原出版, 2017
5) 「臨床・病理 食道癌取扱い規約 第11版」(日本食道学会/編), 金原出版, 2015
6) 「胃癌取扱い規約 第15版」(日本胃癌学会/編), 金原出版, 2017
7) 「膵癌取扱い規約 第7版」(日本膵臓学会/編), 金原出版, 2016
8) 「原発性肝癌取り扱い規約 第6版」(日本肝癌研究会/編), 金原出版, 2015
9) 「臨床・病理 胆道癌取扱い規約 第6版」(日本肝胆膵外科学会/編), 金原出版, 2013
10) 「大腸癌取扱い規約 第9版」(大腸癌研究会/編), 金原出版, 2018
11) 「画像診断のためのリンパ節カラーアトラス」(汲田伸一郎/監, 町田幹, 他/編), 金原出版, 2015

最近チェックした商品履歴

Loading...